Duncan McHale

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Marella Thorell, Attorney-in-Fact for Duncan McHale
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Duncan McHale:

Company Role Class Num Shares Value Price $ Report Date Ownership
Evelo Biosciences, Inc. Chief Medical Officer Common Stock 16,984 $5,605 $0.3300 08 Nov 2023 Direct
Evelo Biosciences, Inc. Chief Medical Officer Restricted Stock Units 6,500 07 Nov 2023 Direct

Insider Reports Filed by Duncan McHale

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000169466523000178-mchale-duncan-2023-11-07 Evelo Biosciences, Inc. 07 Nov 2023 3 -$1,024 4 Chief Medical Officer 08 Nov 2023, 20:32
/report/000169466523000168-mchale-duncan-2023-11-01 Evelo Biosciences, Inc. 01 Nov 2023 3 -$2,262 4 Chief Medical Officer 03 Nov 2023, 16:11
/report/000169466523000154-mchale-duncan-2023-09-11 Evelo Biosciences, Inc. 11 Sep 2023 1 $0 4 Chief Medical Officer 13 Sep 2023, 20:54
/report/000169466523000134-mchale-duncan-2023-08-07 Evelo Biosciences, Inc. 07 Aug 2023 3 -$32,657 4 Chief Medical Officer 09 Aug 2023, 20:42
/report/000169466523000054-mchale-duncan-2023-05-08 Evelo Biosciences, Inc. 08 May 2023 1 -$8,375 4 Chief Medical Officer 10 May 2023, 21:32
/report/000169466523000041-mchale-duncan-2023-05-07 Evelo Biosciences, Inc. 07 May 2023 2 $0 4 Chief Medical Officer 09 May 2023, 16:08
/report/000169466523000011-mchale-duncan-2023-02-07 Evelo Biosciences, Inc. 07 Feb 2023 1 $0 4 Chief Medical Officer 09 Feb 2023, 15:28
/report/000169466522000087-mchale-duncan-2022-05-27 Evelo Biosciences, Inc. 27 May 2022 1 +$49,999 4 Chief Medical Officer 31 May 2022, 16:15
/report/000169466522000017-mchale-duncan-2022-01-19 Evelo Biosciences, Inc. 19 Jan 2022 1 $0 4 Chief Medical Officer 21 Jan 2022, 15:53